Clinical Trial Update: Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating switching or adding pegylated interferon in chronic hepatitis B patients on long-term oral antiviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Seng Gee Lim | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED